Rezolute, Inc. Alternatives & Competitors
12 companies similar to Rezolute, Inc. — Rezolute is developing transformative therapeutics for rare and metabolic diseas...
Companies similar to Rezolute, Inc.
Eiger BioPharmaceuticals
Developing innovative therapies to treat and cure rare metabolic diseases
Allena Pharmaceuticals, Inc.
Developing Therapeutics for Patients with Rare and Severe Metabolic and Kidney Disorders
Soligenix, Inc.
We are a late-stage biopharmaceutical company focused on developing & commercializing prod...
Eloxx Pharmaceuticals
Clinical-stage biopharma company developing novel RNA-modulating drug candidates to treat...
Rival Readout
Competing with Rezolute, Inc.? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Therachon
Life-Transforming Therapies - Developing novel therapeutics for serious rare conditions
AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
Avalo Therapeutics
Innovation driven by compassion.
Versantis
Multiorgan support for rare pediatric and acute liver diseases
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader...
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver dise...
X4 Pharmaceuticals
Enabling a better future for people with rare immune disorders
About Rezolute, Inc.
Rezolute, Inc. is a clinical stage biopharmaceutical company founded in 2010, dedicated to the development of innovative drug therapies targeting metabolic and rare diseases. Through its transformative therapeutics, Rezolute aims to significantly enhance the quality of life for patients suffering from these conditions.
Clinical-stage Biopharmaceutical Company, Drug Development, Metabolic Diseases, Orphan Diseases, Therapeutics, Antibody Therapy, Diabetes Management, Rare Diseases, Plasma Kallikrein Inhibitor, Clinical Trials, Biopharma Innovation, Patient-focused Therapies
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Rezolute, Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Rezolute, Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.